ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

January 19, 2024

https://www.globenewswire.com/news-release/2023/11/30/2788408/0/en/ProKidney-Appoints-Nikhil-Pereira-Kamath-MBA-as-Chief-Business-Officer.html

WINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq:PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Nikhil Pereira-Kamath, MBA, Vice President of Business Development & Innovative Solutions, to Chief Business Officer (CBO). As CBO, Nikhil will have global responsibility for commercial strategy, defining the Company’s growth and partnering activities, business development, and investor relations.

Read more at globenewswire.com

Related news for (PROK)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.